Labcorp Holdings Inc(NYSE:LH)高级副总裁兼首席会计官Peter J. Wilkinson于2026年3月27日以每股267.05美元的价格出售了1,633股普通股,总价值为436,092美元。该交易发生时,该股票交易价格接近266美元,公司市值为219.7亿美元,市盈率为25.54倍。 根据向美国证券交易委员会提交的Form 4文件,该交易是根据符合10b5-1规则的计 ...

Labcorp Holdings Inc(NYSE:LH)运营执行副总裁Jonathan C. Meltzer于2026年3月27日以每股$267.05的价格出售了839股普通股,总价值$224,054。该出售价格略高于当前股价$266.84。

Labcorp Holdings (NYSE:LH) is expanding its New York footprint through the acquisition of assets and operations from Crouse ...

Labcorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Labcorp completes Crouse Health lab asset acquisition, taking over 12 patient service centers and inpatient lab operations in ...

Shares of Labcorp Holdings Inc. LH slid 1.77% to $265.84 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 1.36% to 6,624.70 ...

Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...

Illumina and Labcorp expand collaboration to advance precision oncology through innovative applications of NGS solutions: San Diego Friday, March 20, 2026, 15:00 Hrs [IST] Illumin ...

The deal, which will see Labcorp run 12 patient service centers, is part of the company’s ongoing efforts to expand through ...

Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth ...

Labcorp is continuing its push into New York as it has completed its acquisition of select assets of Crouse Health's ...